Marcum Wealth, LLC Abb Vie Inc. Transaction History

Marcum Wealth, LLC

$1.06 Billion
Q3 2024

A detailed history of Marcum Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Marcum Wealth, LLC holds 9,752 shares of ABBV stock, worth $1.76 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

9,752

Previous 10,105 3.49%

Holding current value

$1.76 Million

Previous $1.73 Million 11.08%

% of portfolio

0.18%

Previous 0.18%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$163.84 - $199.33 $57,835 - $70,363	-353 Reduced 3.49%	9,752 $1.93 Million
Q2 2024 Jul 02, 2024	BUY	$154.79 - $180.76 $4,798 - $5,603	31 Added 0.31%	10,105 $1.73 Million
Q1 2024 Apr 10, 2024	SELL	$159.82 - $182.1 $98,449 - $112,173	-616 Reduced 5.76%	10,074 $1.83 Million
Q4 2023 Jan 10, 2024	BUY	$137.6 - $154.97 $28,208 - $31,768	205 Added 1.96%	10,690 $1.66 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $63,856 - $73,922	-478 Reduced 4.36%	10,485 $1.56 Million
Q2 2023 Jul 13, 2023	BUY	$132.51 - $164.9 $57,774 - $71,896	436 Added 4.14%	10,963 $1.48 Million
Q1 2023 Apr 19, 2023	BUY	$144.61 - $166.54 $4,193 - $4,829	29 Added 0.28%	10,527 $1.68 Million
Q4 2022 Jan 12, 2023	SELL	$138.31 - $165.87 $11,203 - $13,435	-81 Reduced 0.77%	10,498 $0
Q3 2022 Oct 11, 2022	BUY	$134.21 - $153.93 $6,844 - $7,850	51 Added 0.48%	10,579 $1.42 Million
Q2 2022 Jul 14, 2022	BUY	$137.62 - $174.96 $51,745 - $65,784	376 Added 3.7%	10,528 $1.61 Million
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $134,883 - $167,352	-1,022 Reduced 9.15%	10,152 $1.65 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $3,652 - $4,621	34 Added 0.31%	11,174 $1.51 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $79,480 - $90,222	747 Added 7.19%	11,140 $1.2 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $4,734 - $5,274	45 Added 0.43%	10,393 $1.17 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $730,422 - $804,106	7,140 Added 222.57%	10,348 $1.12 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $64,633 - $87,262	803 Added 33.39%	3,208 $344,000
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $3,350 - $3,932	-39 Reduced 1.6%	2,405 $211,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $179,316 - $239,951	2,444 New	2,444 $240,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marcum Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marcum Wealth, LLC with notifications on news.

Account

Marcum Wealth, LLC Abb Vie Inc. Transaction History